{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:08:09Z","timestamp":1775084889252,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.parkreldis.2010.07.006","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T04:59:08Z","timestamp":1281589148000},"page":"608-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients"],"prefix":"10.1016","volume":"16","author":[{"given":"D.A.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seibyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Marek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2010.07.006_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.parkreldis.2008.04.037","article-title":"Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease","volume":"15","author":"Hall","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl. 3","key":"10.1016\/j.parkreldis.2010.07.006_bib3","first-page":"A388","article-title":"Prevalence of FMR1 gray zone alleles is increased in female patients with parkinsonism","volume":"72","author":"Hall","year":"2009","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"10.1016\/j.parkreldis.2010.07.006_bib4","first-page":"IV37","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson\u2019s disease?","volume":"252","author":"Fahn","year":"2005","journal-title":"J Neurol"},{"issue":"15","key":"10.1016\/j.parkreldis.2010.07.006_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/01.wnl.0000277648.63931.c0","article-title":"Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease","volume":"69","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.parkreldis.2010.07.006_bib6","first-page":"A274","article-title":"Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study","volume":"64","author":"Marek","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","article-title":"(123I) \u03b2-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis","volume":"61","author":"Jennings","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/jcbfm.1994.131","article-title":"Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects","volume":"14","author":"Laruelle","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib9","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.90.24.11965","article-title":"Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease","volume":"90","author":"Innis","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.wnl.0000188821.51055.52","article-title":"Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers","volume":"65","author":"Ceravolo","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V","article-title":"Clinical involvement and protein expression in individuals with the FMR1 premutation","volume":"91","author":"Tassone","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.parkreldis.2010.07.006_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jmg.2006.043950","article-title":"Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats","volume":"44","author":"Loesch","year":"2007","journal-title":"J Med Genet"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010001719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010001719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:12:12Z","timestamp":1761178332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802010001719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1353802010001719"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.07.006","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}